Epidemiology


Etiology


Pathophysiology


Clinical features


  • Ego-dystonic: behavior or thought patterns that are inconsistent with or repulsive to one’s sense of self
    • Opposite of ego-syntonic
      • Behavior patterns are in agreement with one’s sense of self
      • Seen in obsessive-compulsive personality disorder
  • Obsessions: distressing thoughts, emotions, and/or sensations that are recurring and intrusive
  • Compulsions: repetitive actions to provide relief from anxiety caused by obsessions (can take up a substantial amount of time)

Mnemonic

Compulsions are actions to calm down.

Diagnostics


Treatment


  • First-line:
    • Psychotherapy: Cognitive Behavioral Therapy (CBT) utilizing Exposure and Response Prevention (ERP).
    • Pharmacotherapy: SSRIs (e.g., fluoxetine, sertraline, fluvoxamine, paroxetine).
      • Requires higher doses and longer duration (8–12 weeks) for clinical trial compared to MDD.
    • Combination therapy: CBT (ERP) + SSRI is first-line for moderate-to-severe disease. c
  • Second-line:
    • Switch to a different SSRI or switch to Venlafaxine (SNRI).
    • Clomipramine (TCA): Highly effective due to potent serotonergic action, but reserved for 2nd/3rd line due to anticholinergic, antihistaminic, and cardiac (QT prolongation, arrhythmia) toxicity risk.
  • Refractory:
    • Augmentation of SSRI with atypical antipsychotics (e.g., low-dose risperidone, aripiprazole).
    • Invasive interventions for severe, disabling, treatment-resistant OCD:
      • Deep Brain Stimulation (DBS).
      • Surgical neuroablation (e.g., anterior capsulotomy, cingulotomy).